Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables Refunds
Ratios

Keros Therapeutics (KROS) Preferred Shares Issued (2020)

Keros Therapeutics' Preferred Shares Issued history spans 1 years, with the latest figure at $56.0 million for Q1 2020.

  • For Q1 2020, Preferred Shares Issued changed N/A year-over-year to $56.0 million; the TTM value through Dec 2020 reached $56.0 million, changed N/A, while the annual FY2020 figure was $56.0 million, N/A changed from the prior year.
  • Preferred Shares Issued reached $56.0 million in Q1 2020 per KROS's latest filing.
  • In the past five years, Preferred Shares Issued ranged from a high of $56.0 million in Q1 2020 to a low of $56.0 million in Q1 2020.